advertisement

Topcon

Varma R 14

Showing records 1 to 14 | Display all abstracts from Varma R

70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Fini ME
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Zhang X
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Schwartz SG
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Dastiridou A; Francis BA
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Gao X; Jeong S
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Tan O
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Patel N
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Varma R; Greenfield DS
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Itakura T; Price MO
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Schuman JS; Sehi M
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Price FW
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Chopra V
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Varma R; Stamer WD
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Huang D;
American Journal of Ophthalmology 2016; 172: 94-103

Issue 18-2

Change Issue


advertisement

Topcon